跳至主要内容
临床试验/ISRCTN63745549
ISRCTN63745549已完成未知

Smart Technologies for personAlised Nutrition and Consumer Engagement (Stance4Health)

niversity of Granada0 个研究点目标入组 408 人开始时间: 2021年10月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
408

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35627049/ (added 31/05/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Study population 1 (normal-weight and overweight adults):
  • 1. Age 20 - 65 years
  • 2. Apparently healthy
  • 3. BMI 20-28 kg/m²
  • 4. Weight stable
  • 5. Use of smartphone
  • 6. Internet connection
  • Study population 2:
  • 1. BMI =95 percentile for age, gender and height, males 6-11 years, females 6-11 years
  • 2. Diagnosed with celiac disease, aged 6-11 years, on elimination (gluten-free) diet and allergic to gluten (very few), on elimination (gluten-free) diet
  • 3. Age males 6-11-years, females 6-11 years and one of the following:
  • 3.1. IgE-mediated milk allergy, on elimination diet from infancy
  • 3.2. Lactose intolerance (symptoms plus breath hydrogen positive test)
  • 3.3. Overgrown IgE-mediated milk allergy but current aversion for milk
  • 3.4. Nondefinable phenotype (children who avoid milk but do not belong to any of the previous phenotypes)
  • 4. BMI >5th and <85th percentile for age, gender, and height, age: males 6-11 years, females 6-11 years
  • Updated 22/07/2022:
  • Study population 2:
  • 1. BMI =95 percentile for age, gender and height, males 5-11 years, females 5-11 years
  • 2. Diagnosed with celiac disease, aged 5-11 years, on elimination (gluten-free) diet and allergic to gluten (very few), on elimination (gluten-free) diet
  • 3. Age males 5-11 years, females 5-11 years and one of the following:
  • 3.1. IgE-mediated milk allergy, on elimination diet from infancy
  • 3.2. Lactose intolerance (symptoms plus breath hydrogen positive test)
  • 3.3. Overgrown IgE-mediated milk allergy but current aversion for milk
  • 3.4. Nondefinable phenotype (children who avoid milk but do not belong to any of the previous phenotypes)
  • 4. BMI >5th and <85th percentile for age, gender, and height, age: males 5-11 years, females 5-11 years

排除标准

  • Study population 1 (normal-weight and overweight adults):
  • 1. Diagnosis of chronic GI disorders, diabetes, celiac disease, or chronic diseases
  • 2. Present pregnancy or lactation (<6 weeks prior to study start), or planning to get pregnant
  • 3. Recent inflammation and/or long-term use of anti-inflammatory drugs
  • 4. Medically prescribed diet or specific dietary regimens for any reasons (i.e. high-protein diet, vegetarianism, veganism, etc)
  • 5. Antibiotic treatment (<3 months prior to study start)
  • 6. Intake of antioxidant, pre- or probiotic supplements (< 1 month prior to study start)
  • 7. Intense physical activity (>10 h/week)
  • 8. Alcohol consumption >21 drinks/week for men and >14 drinks/week for women
  • Study population 2:
  • 1. GI disease, endocrinopathies, probiotics in the last 2 weeks
  • 2. Never symptoms
  • 3. Other gastrointestinal comorbidities
  • 4. Chronic GI disorders, any other chronic disease, elimination diet, probiotics in the last 2 weeks

研究者

发起方
niversity of Granada

相似试验